New diabetes drug combo shows promise in japanese patients
NCT ID NCT01026194
Summary
This study tested whether adding a new drug called Teneligliptin to an existing diabetes medication (pioglitazone) could better control blood sugar in Japanese adults with type 2 diabetes. It involved 204 participants who took the drug combination for up to 52 weeks. The main goal was to see if this combination was safe and effective at lowering long-term blood sugar levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Study site
Shinjukuku, Tokyo, Japan
Conditions
Explore the condition pages connected to this study.